Regulation 31(4) - SAST Disclosure
Filed with BSE · · 2 pages · English
Subject: Disclosure under Regulation 31(4) of SEBI (SAST) Regulations, 2011 Please find enclosed herewith the annual declaration received from the Promoters/Promoter Group of the Company under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for the financial year ended March 31, 2026. The Promoters/Promoter Group have confirmed that they have not ma
Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 30 2026
- Announcement under Regulation 30 (LODR)-Change in Management
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 27 2026
- Board Meeting Outcome for Modification Of Draft Scheme Of Amalgamation
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 26 2026
Later from Venmax Drugs & Pharmaceuticals
- Board Meeting Intimation for Audited Standalone Financial Results Of The Company For The Quarter And Year Ended March 31, 2026.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release May 06 2026
- Closure of Trading Window
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jun 27 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals